Cytek Biosciences, Inc.CTKBNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 93 | 128↑37.8% | 164↑28.2% | 193↑17.7% | 200↑3.9% |
| Gross Profit | 52 | 79↑53.1% | 101↑27.6% | 109↑8.4% | 111↑1.5% |
| Operating Income | 14 | 9↓33.0% | -2↓119.7% | -28↓1443.5% | -21↑26.3% |
| Net Income | 19 | 3↓84.5% | 3↓14.2% | -12↓571.6% | -6↑50.4% |
| EBITDA | 15 | 9↓41.9% | 9↑6.4% | -4↓146.4% | -10↓127.6% |
| EPS Diluted | 0.02 | 0.03↑36.4% | 0.02↓43.6% | -0.09↓582.8% | -0.05↑48.7% |